HONG KONG – Underscoring the clouds hanging over China’s pharmaceutical and biotechnology industries, Shanghai Pharmaceuticals Holding Co Ltd. reported double-digit growth in the third quarter of the year, but the mostly positive results were tarred by coming in below expectations.